Dr. Fernando Ibarra, MD

Dr. Ibarra practices at Plaza Surgical Center - Monterey Park in Monterey Park, California.

Dr. Ibarra's NPI, 1013082726, was assigned on November 21, 2006. Dr. Ibarra graduated from Universidad Autonoma de Guadalajara in 1979. Dr. Ibarra holds California license A38493.

Dr. Ibarra's primary practice is Plaza Surgical Center - Monterey Park, at 850 South Atlantic Blvd, Suite 201, Monterey Park, CA 91754. The practice phone is (626) 289-2894.

Dr. Ibarra's primary practice is Plaza Surgical Center - Monterey Park in Monterey Park, California. Dr. Ibarra is also affiliated with Monterey Park Hospital. The medical group on file is Gastroenterology Medical of Los Angeles (Gastroenterology Diagnostic Center). Dmand AI also links Dr. Ibarra to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ibarra practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ibarra's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ibarra is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Ibarra is licensed in California.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy and fatty liver among the conditions Dr. Ibarra treats.

CMS data shows 1,296 Medicare services from Dr. Ibarra across 16 procedure codes in 2024, for 635 Medicare patients. Medicare paid $130,125 for them.

CMS counts 635 Medicare patients who saw Dr. Ibarra in 2024. The largest group is 65 to 74, with 364 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 91% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ibarra's median patient age at 61, with 61% women.

In 2024, Dr. Ibarra wrote 2,502 Medicare Part D claims for 1,144 patients. 90% of them were for generic drugs. CMS names the drug for 2,332 of them, across 21 drugs with 11 or more claims each, at $187,401 in total drug cost. In 2023, CMS named 2,167 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ibarra for performance year 2024, reported individually. Dr. Ibarra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 737 procedures of colonoscopy by Dr. Ibarra, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 28 papers to Dr. Ibarra, published from 2003 to 2015. 2008 was the busiest year, with 2. The most frequent topics are Rats, Wistar, Dopamine and Sodium-Potassium-Exchanging ATPase. Dr. Ibarra has published most often in Acta Physiol Scand. Dr. Ibarra's most frequent co-author is Sam X. Cheng, MD.

CMS Open Payments shows 8 general payments to Dr. Ibarra from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Ardelyx, Inc. paid the most, $118.

Dmand AI lists 2 awards for Dr. Ibarra.

Dr. Ibarra graduated from Universidad Autonoma de Guadalajara in 1979. Dr. Ibarra is a member of ACG.

Dr. Ibarra is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and LA Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.